ResMed Inc.
MX ˙ BMV ˙ US7611521078
SecurityMX:RMD / ResMed Inc.
InstitutionWealthfront Advisers Llc
Latest Disclosed Ownership10,514 shares
Latest Disclosed Value $ 2,360,183
Wealthfront Advisers Llc reports 13.79% decrease in ownership of RMD / ResMed Inc.

On May 5, 2026 - Wealthfront Advisers Llc filed a 13F-HR form disclosing ownership of 10,514 shares of ResMed Inc. (MX:RMD) valued at $2,360,183 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 12,196 shares of ResMed Inc.. This represents a change in shares of -13.79% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-05 2026-03-31 13F RESMED COM 761152107 10,514 -1,682 -13.79 2,360 -19.65 0.0052
2026-01-30 2025-12-31 13F RESMED COM 761152107 12,196 -1,643 -11.87 2,938 -22.47 0.0066
2025-11-06 2025-09-30 13F RESMED COM 761152107 13,839 209 1.53 3,788 7.74 0.0089
2025-07-31 2025-06-30 13F RESMED COM 761152107 13,630 4,250 45.31 3,517 67.51 0.0091
2025-05-02 2025-03-31 13F RESMED COM 761152107 9,380 1,338 16.64 2,100 14.14 0.0056
2025-04-01 2024-12-31 13F/A-1 RESMED COM 761152107 8,042 224 2.87 1,839 -3.62 0.0054
2025-02-07 2024-12-31 13F RESMED COM 761152107 42,768 34,950 1,496 0.0045
2024-11-12 2024-09-30 13F RESMED COM 761152107 7,818 734 10.36 1,909 40.71 0.0059
2024-08-14 2024-06-30 13F RESMED COM 761152107 7,084 -186 -2.56 1,356 -5.77 0.0046
2024-04-19 2024-03-31 13F RESMED COM 761152107 7,270 15 0.21 1,440 15.30 0.0050
2024-02-09 2023-12-31 13F RESMED COM 761152107 7,255 2,583 55.29 1,248 80.87 0.0048
2023-11-01 2023-09-30 13F RESMED COM 761152107 4,672 -4,376 -48.36 691 -65.08 0.0030
2023-08-07 2023-06-30 13F RESMED COM 761152107 9,048 -794 -8.07 1,977 -8.31 0.0084
2023-04-28 2023-03-31 13F RESMED COM 761152107 9,842 257 2.68 2,155 8.07 0.0098
2023-02-10 2022-12-31 13F RESMED COM 761152107 9,585 -1,314 -12.06 1,995 -16.18 0.0097
2022-11-14 2022-09-30 13F RESMED COM 761152107 10,899 515 4.96 2,379 9.28 0.0127
2022-07-20 2022-06-30 13F RESMED COM 761152107 10,384 2,217 27.15 2,177 9.89 0.0109
2022-05-16 2022-03-31 13F RESMED COM 761152107 8,167 -271 -3.21 1,981 -9.87 0.0087
2022-01-21 2021-12-31 13F RESMED COM 761152107 8,438 -402 -4.55 2,198 -5.67 0.0093
2021-11-15 2021-09-30 13F RESMED COM 761152107 8,840 862 10.80 2,330 18.45 0.0108
2021-08-16 2021-06-30 13F RESMED COM 761152107 7,978 21 0.26 1,967 27.40 0.0093
2021-05-14 2021-03-31 13F RESMED COM 761152107 7,957 258 3.35 1,544 -5.68 0.0083
2021-02-16 2020-12-31 13F RESMED COM 761152107 7,699 -489 -5.97 1,637 16.60 0.0098
2020-11-16 2020-09-30 13F RESMED COM 761152107 8,188 462 5.98 1,404 -5.33 0.0100
2020-08-14 2020-06-30 13F RESMED COM 761152107 7,726 -1,299 -14.39 1,483 11.59 0.0115
2020-05-15 2020-03-31 13F RESMED COM 761152107 9,025 4,864 116.89 1,329 106.05 0.0121
2020-01-21 2019-12-31 13F RESMED COM 761152107 4,161 -16 -0.38 645 14.36 0.0048
2019-10-15 2019-09-30 13F RESMED COM 761152107 4,177 161 4.01 564 15.10 0.0047
2019-08-13 2019-06-30 13F RESMED COM 761152107 4,016 -412 -9.30 490 6.52 0.0043
2019-05-13 2019-03-31 13F RESMED COM 761152107 4,428 48 1.10 460 -7.82 0.0043
2019-02-14 2018-12-31 13F RESMED COM 761152107 4,380 4,380 499 0.0053
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.